Caribou Biosciences Inc

CRBU NPV
Create an alert
Sell$1.56
Buy$1.57
$0.07 (4.33%)
Last updated today at 03:46 UTC

Key metrics

Open$1.50
Previous close$1.50
Market cap$144.80m
P/E ratio-
Volume294,668
Dividend yield0.00%
EMS-

Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. The Company is dedicated to developing transformative therapies ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue99.18m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.